Risultati della ricerca - Jason Lickliter
- Mostra 1 - 3 risultati su 3
-
1
A phase I randomized, double‐blinded, placebo‐controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects di Jason Lickliter, Shuang Wang, Wenxin Zhang, Huaqiang Zhu, Jing Wang, Congqiao Zhao, Haige Shen, Yu Wang
Pubblicazione 2023Collocazione: Caricamento...Connect to this object online.
Localizzazione: Caricamento...
Libro -
2
A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults di Rupert Davies, Stanford L. Peng, Jason Lickliter, Kristi McLendon, Amanda Enstrom, Allison G. Chunyk, Lori Blanchfield, NingXin Wang, Tiffany Blair, Heather M. Thomas, Alina Smith, Stacey R. Dillon
Pubblicazione 2024Collocazione: Caricamento...Connect to this object online.
Localizzazione: Caricamento...
Libro -
3
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults di Susan B. Manoff, Michele Sausser, Amy Falk Russell, Jason Martin, David Radley, Donna Hyatt, Christine C. Roberts, Jason Lickliter, Janakan Krishnarajah, Andrew Bett, Sheri Dubey, Tyler Finn, Beth-Ann Coller
Pubblicazione 2019Collocazione: Caricamento...Connect to this object online.
Localizzazione: Caricamento...
Libro